Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Labovitz

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
European Journal of Clinical Investigation|February 26, 2019
Pulse pressure and prognosis in patients with heart failure with reduced ejection fractionNeeraj Shah, Min Qian, Marco R Di Tullio, et al.
Frontiers in Neurology|October 18, 2019
Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation-A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial FibrillationDavid Z Rose, John N Meriwether, Michael G Fradley, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 8, 2013
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trialPatrick M Pullicino, John L P Thompson, Ralph L Sacco, et al.
International Journal of Cardiology|December 3, 2014
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trialJonathan A Shaffer, John L P Thompson, Bin Cheng, et al.
JACC. Heart Failure|August 5, 2017
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF TrialJohn R Teerlink, Min Qian, Natalie A Bello, et al.
ESC Heart Failure|July 18, 2018
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatmentMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Stroke|June 30, 2016
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction TrialMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Circulation. Heart Failure|July 25, 2013
Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trialShunichi Homma, John L P Thompson, Alexandra R Sanford, et al.
Journal of Cardiology|November 10, 2015
The first prognostic model for stroke and death in patients with systolic heart failureRonald S Freudenberger, Bin Cheng, Douglas L Mann, et al.
European Journal of Heart Failure|July 23, 2016
CHA<sub>2</sub> DS<sub>2</sub> -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythmSiqin Ye, Min Qian, Bo Zhao, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
European Journal of Clinical Investigation|February 26, 2019
Pulse pressure and prognosis in patients with heart failure with reduced ejection fractionNeeraj Shah, Min Qian, Marco R Di Tullio, et al.
Frontiers in Neurology|October 18, 2019
Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation-A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial FibrillationDavid Z Rose, John N Meriwether, Michael G Fradley, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 8, 2013
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trialPatrick M Pullicino, John L P Thompson, Ralph L Sacco, et al.
International Journal of Cardiology|December 3, 2014
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trialJonathan A Shaffer, John L P Thompson, Bin Cheng, et al.
JACC. Heart Failure|August 5, 2017
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF TrialJohn R Teerlink, Min Qian, Natalie A Bello, et al.
ESC Heart Failure|July 18, 2018
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatmentMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Stroke|June 30, 2016
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction TrialMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Circulation. Heart Failure|July 25, 2013
Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trialShunichi Homma, John L P Thompson, Alexandra R Sanford, et al.
Journal of Cardiology|November 10, 2015
The first prognostic model for stroke and death in patients with systolic heart failureRonald S Freudenberger, Bin Cheng, Douglas L Mann, et al.
European Journal of Heart Failure|July 23, 2016
CHA<sub>2</sub> DS<sub>2</sub> -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythmSiqin Ye, Min Qian, Bo Zhao, et al.
Pageof 18